Publications by authors named "Laura Santoni"

Claim this Profile
C
Cost-Consequence Analysis of Natalizumab Compared with Other High-Efficacy Treatments in Patients with Relapsing-Remitting Multiple Sclerosis.
Luca Prosperini, Vincenzo Brescia Brescia Morra, Carla Fornari, Laura Santoni, Daria Perini

Pharmacoeconomics· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Minimization Analysis and Budget Impact Analysis About Subcutaneous Natalizumab in Relapsing-Remitting Multiple Sclerosis in Italy.
Luca Prosperini, Lorenzo Pradelli, Laura Santoni, Daria Perini, Salvatore Cottone

Clinicoecon Outcomes Res· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of multiple sclerosis in an Italian cohort of patients on disease-modifying therapy: analysis of disease cost and its components.
Michela Ponzio, Laura Santoni, Michela Molina, Eleonora Tavazzi, Roberto Bergamaschi

J Neurol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous or subcutaneous natalizumab in patients with relapsing-remitting multiple sclerosis: investigation on efficiency and savings-the EASIER study.
Massimo Filippi, Luigi Grimaldi, Antonella Conte, Rocco Totaro, Maria Rosaria Valente, Laura Santoni

J Neurol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare resource utilization and costs for extended interval dosing of natalizumab in multiple sclerosis.
Marcello Moccia, Ilaria Loperto, Laura Santoni, Silvia Masera, Giuseppina Affinito

Neurodegener Dis Manag· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of escalating to natalizumab or switching among immunomodulators in relapsing-remitting multiple sclerosis in Italy.
Gianluca Furneri, Laura Santoni, Chiara Ricella, Luca Prosperini

BMC Health Serv Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy.
Damiano Paolicelli, Sergio Iannazzo, Laura Santoni, Antonio Iaffaldano, Valentina Di Lecce

PLoS One· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy.
Koo Wilson, Robert Hettle, Sophie Marbaix, Silvia Diaz Cerezo, Monica Ines, Laura Santoni

Eur J Prev Cardiol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of first-ever stroke in Valle d'Aosta, Italy: linking clinical registries and administrative data.
Edo Bottacchi, Giovanni Corso, Piera Tosi, Massimo Veronese Morosini, Giuseppe De Filippis, Laura Santoni

BMC Health Serv Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis